CCL13 and ovarian carcinoma: The results showed that the overexpression of MCP-4 significantly enhanced the invasive ability of Caov3 and ES-2 cells (P < 0.05) (Figure 4A), whereas the inhibition of MCP-4 expression decreased the invasive ability of ovarian cancer cells (P < 0.05) (Figure 4B).